S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer Read more about S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors Read more about Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) Read more about A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer Read more about Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery Read more about A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer Read more about Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Read more about Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Real-time Activity Monitoring to Prevent Admissions During RadioTherapy Read more about Real-time Activity Monitoring to Prevent Admissions During RadioTherapy
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions Read more about Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Read more about Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery